KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $181.0 million.

  • Medtronic's Interest Expenses fell 1339.71% to $181.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $710.0 million, marking a year-over-year decrease of 731.07%. This contributed to the annual value of $729.0 million for FY2025, which is 139.08% up from last year.
  • As of Q4 2025, Medtronic's Interest Expenses stood at $181.0 million, which was down 1339.71% from $176.0 million recorded in Q3 2025.
  • In the past 5 years, Medtronic's Interest Expenses ranged from a high of $209.0 million in Q4 2024 and a low of $118.0 million during Q4 2022
  • Its 5-year average for Interest Expenses is $163.9 million, with a median of $167.0 million in 2023.
  • As far as peak fluctuations go, Medtronic's Interest Expenses tumbled by 7106.38% in 2021, and later skyrocketed by 5254.24% in 2023.
  • Quarter analysis of 5 years shows Medtronic's Interest Expenses stood at $136.0 million in 2021, then fell by 13.24% to $118.0 million in 2022, then skyrocketed by 52.54% to $180.0 million in 2023, then increased by 16.11% to $209.0 million in 2024, then fell by 13.4% to $181.0 million in 2025.
  • Its last three reported values are $181.0 million in Q4 2025, $176.0 million for Q3 2025, and $174.0 million during Q2 2025.